NASDAQ · LUNG
Pulmonx Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for LUNG has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Dec 2026 | $-0.23 | $-0.22 | $-0.23 | 2 |
| Mar 2027 | $-0.28 | $-0.28 | $-0.28 | 2 |
| Jun 2027 | $-0.19 | $-0.19 | $-0.19 | 1 |
| Sep 2027 | $-0.23 | $-0.23 | $-0.23 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · The Motley Fool · MarketBeat · Zacks- RTTNews · Oct 29, 11:10 AM EDTPulmonx Reports 6% Q3 Revenue Growth, Narrows Loss And Maintains 2026 Revenue Outlook(RTTNews) – Pulmonx Corporation (LUNG), on Wednesday reported third-quarter 2026 worldwide revenue of $22.8 million, up 6% from $21.5 million in the year-ago quarter, as the company returned to year-over-year revenue growth.
- RTTNews · Oct 28, 3:16 PM EDTBiotech Stocks Rise: GMAB Surges, LUNG And AXGN Gain Over 30%(RTTNews) – Shares of several biotech companies moved higher following quarterly financial results, clinical trial developments and business updates. Genmab reported positive Phase 3 results for its cancer drug combination, Pulmonx posted improved quarterly results, Axogen and Or
- The Motley Fool · Oct 27, 7:43 PM EDTPulmonx (LUNG) Q3 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Oct 27, 7:04 PM EDTWhat Pulmonx (LUNG) Said on Its Q3 Earnings CallPulmonx (NASDAQ:LUNG) reported third-quarter revenue growth and a narrower loss as the company cited progress in rebuilding its U.S. sales organization, tightening expenses and advancing clinical programs intended to expand its market. Total worldwide revenue for the quarter end
- Zacks · Oct 27, 5:20 PM EDTPulmonx Corporation (LUNG) Reports Q3 Loss, Tops Revenue EstimatesPulmonx (LUNG) delivered earnings and revenue surprises of +26.92% and +3.75%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 26, 9:55 AM EDTPulmonx Corporation (LUNG) Now Trades Above Golden Cross: Time to Buy?Is it a good or bad thing when a stock experiences a golden cross technical event?
- MarketBeat · Aug 15, 2:01 AM EDTPulmonx Rebuilds Sales Force, Targets Growth and AeriSeal Launch Next YearPulmonx (NASDAQ:LUNG) is rebuilding its sales organization, targeting a return to growth and preparing for potential commercialization of its AeriSeal therapy outside the United States in the second half of next year, President and CEO Glen French said during a Canaccord fireside
- Zacks · Aug 14, 12:00 PM EDTWhat Makes Pulmonx Corporation (LUNG) a Strong Momentum Stock: Buy Now?Does Pulmonx Corporation (LUNG) have what it takes to be a top stock pick for momentum investors? Let's find out.
- The Motley Fool · Aug 7, 9:02 PM EDTPulmonx (LUNG) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- RTTNews · Aug 3, 10:31 PM EDTTop Biotech Gainers: UPC Cuts Loss, CPIX Gains Ahead Of Q2 Results, AUTL Builds Commercial Momentum(RTTNews) – Today's top biotech gainers include Universe Pharmaceuticals, which recently filed its SEC report for the six months ended March 31, 2026; Cumberland Pharma, ahead of its second-quarter 2026 financial results due Tuesday; and Autolus Therapeutics, following the releas
- BNK Invest · Aug 3, 2:19 PM EDTMonday Sector Leaders: Construction Materials & Machinery, Medical Instruments & SuppliesIn trading on Monday, construction materials & machinery shares were relative leaders, up on the day by about 4.1%. Leading the group were shares of Gibraltar Industries, up about 8.3% and shares of Ferguson Enterprises up about 8.3% on the day. Also showing relative stren
- Zacks · Aug 3, 12:00 PM EDTPulmonx (LUNG) Upgraded to Buy: What Does It Mean for the Stock?Pulmonx (LUNG) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Pulmonx Corporation from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.